According to the research report, the global clinical laboratory tests market size is expected to touch USD 272.61 Billion by 2032, from USD 106.74 Billion in 2022, growing with a significant CAGR of 9.83% from 2023 to 2032.
Key Takeaways:
- North America Region is predicted to dominate the market between 2023 and 2032.
- Asia-Pacific is expected to expand at the fastest CAGR from 2023 to 2032.
- By Type, the HbA1c tests segment generated for the maximum market share in 2022.
- By Type, the HGB/HCT tests segment is expected to expand at the fastest CAGR between 2023 and 2032.
- By End-use, the Primary clinic segment captured the major market share in 2022.
- By End-use, the central laboratories segment is projected to grow at a remarkable CAGR between 2023 and 2032.
The clinical laboratory tests report offers
a comprehensive study of the current state expected at the major drivers,
market strategies, and key vendors’ growth. The report presents energetic
visions to conclude and study the market size, market hopes, and competitive
surroundings. The research also focuses on the important achievements of the
market, research & development, and regional growth of the leading
competitors operating in the market. The current trends of the global clinical
laboratory tests in conjunction with the geographical landscape of this
vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global clinical laboratory tests market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global clinical laboratory tests during the forecast
period. It also includes a key indicator assessment that highlights growth
prospects of this market and estimates statistics related to growth of the
market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/2748
| Report Coverage | Details |
| Market Size in 2023 | USD 117.23 Billion |
| Market Size by 2032 | USD 272.61 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 9.83% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Type and By End-Use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
This study covers a detailed segmentation
of the global clinical laboratory tests market, along with key information and
a competition outlook. The report mentions company profiles of players that are
currently dominating the global clinical laboratory tests market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- Quest Diagnostics Incorporated.
- Sonic Healthcare Limited.
- Cinven
- ARUP Laboratories
- Abbott
- Clinical Reference Laboratory, Inc.
- Laboratory Corporation of America Holdings
- Synnovis Group LLP
- OPKO Health, Inc.
- UNILABS
Market Segmentation
- Complete Blood Count
- Basic Metabolic Panel Testing
- HGB/ HCT testing
- Comprehensive Metabolic Panel Testing
- BUN Creatinine Testing
- HbA1c Testing
- Electrolytes Testing
- Liver Panel Testing
- Hepatitis
- Liver Cirrhosis
- Bone Disease
- Bile Duct Obstruction
- Liver Cancer
- Autoimmune Disorders
- Others
- Lipid Panel Testing
- Renal Panel Testing
- Cardiovascular Panel Tests
By End-Use
- Central Laboratories
- Complete Blood Count
- Basic Metabolic Panel Testing
- HGB/ HCT testing
- BUN Creatinine Testing
- HbA1c Testing
- Electrolytes Testing
- Comprehensive Metabolic Panel Testing
- Renal Panel Testing
- Liver Panel Testing
- Lipid Panel Testing
- Cardiovascular Panel Tests
- Primary Clinics
- Complete Blood Count
- Cardiovascular Panel Tests
- Basic Metabolic Panel Testing
- HGB/ HCT testing
- Lipid Panel Testing
- BUN Creatinine Testing
- HbA1c Testing
- Electrolytes Testing
- Comprehensive Metabolic Panel Testing
- Renal Panel Testing
- Liver Panel Testing
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global clinical laboratory tests report is based on
detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market association
publications, and company websites to obtain the necessary understanding of the
global clinical laboratory tests market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Clinical Laboratory Tests Market
5.1. COVID-19 Landscape: Clinical Laboratory Tests Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Clinical Laboratory Tests Market, By Type
8.1. Clinical Laboratory Tests Market, by Type, 2023-2032
8.1.1. Complete Blood Count
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Basic Metabolic Panel Testing
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. HGB/ HCT testing
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Comprehensive Metabolic Panel Testing
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. BUN Creatinine Testing
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. HbA1c Testing
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Electrolytes Testing
8.1.7.1. Market Revenue and Forecast (2020-2032)
8.1.8. Liver Panel Testing
8.1.8.1. Market Revenue and Forecast (2020-2032)
8.1.9. Lipid Panel Testing
8.1.9.1. Market Revenue and Forecast (2020-2032)
8.1.10. Renal Panel Testing
8.1.10.1. Market Revenue and Forecast (2020-2032)
8.1.11. Cardiovascular Panel Tests
8.1.11.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Clinical Laboratory Tests Market, By End-Use
9.1. Clinical Laboratory Tests Market, by End-Use, 2023-2032
9.1.1. Central Laboratories
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Primary Clinics
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Clinical Laboratory Tests Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2020-2032)
10.1.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.1.3.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.1.4.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.3.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.4.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.5.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Type (2020-2032)
10.2.6.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.3.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.4.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.5.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Type (2020-2032)
10.3.6.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.3.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.4.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.5.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Type (2020-2032)
10.4.6.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2020-2032)
10.5.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Type (2020-2032)
10.5.3.2. Market Revenue and Forecast, by End-Use (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Type (2020-2032)
10.5.4.2. Market Revenue and Forecast, by End-Use (2020-2032)
Chapter 11. Company Profiles
11.1. Quest Diagnostics Incorporated.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Sonic Healthcare Limited.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Cinven
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. ARUP Laboratories
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Abbott
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Clinical Reference Laboratory, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Laboratory Corporation of America Holdings
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Synnovis Group LLP
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. OPKO Health, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. UNILABS
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments